Sponsors
 |
Ipsen is a global specialty-driven pharmaceutical company with total sales exceeding €1.1 billion in 2011. Ipsen’s ambition is to become a leader in specialty healthcare solutions for targeted debilitating diseases. Its development strategy is supported by four franchises: neurology / Dysport®, endocrinology / Somatuline®, uro-oncology / Decapeptyl® and hemophilia. Moreover, the Group has an active policy of partnerships. R&D is focused on innovative and differentiated technological patientdriven platforms, peptides and toxins. |
 |
The primary objective of Sirtex Medical is to research, develop, and commercialise effective treatments for liver cancer using novel small particle technology. |
 |
Novartis International AG is a multinational pharmaceutical company based in Basel, Switzerland, ranking number two in sales among the world-wide industry in 2010. |
 |
Advanced Accelerator Applications (www.adacap.com), is a European pharmaceutical company founded in 2002 to develop innovative diagnostic and therapeutic products. AAA’s main focus is in the field of Molecular Imaging and individualised therapy for the management of patients with serious conditions (Personalized Medicine). AAA currently has 12 production and R&D facilities able to manufacture both diagnostics and therapeutic Molecular Nuclear Medicine products and more than 200 employees in 9 countries. |
 |
Pfizer is a multinational pharmaceutical corporation headquartered in New York City. It is the world's largest pharmaceutical company by revenues. Pfizer develops and produces medicines and vaccines for a wide range of conditions including in the areas of immunology and inflammation, oncology, cardiovascular and metabolic diseases, neuroscience and pain. |
 |
Covidien is a $12 billion global healthcare products leader dedicated to innovation and long-term growth. Covidien creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. |
 |
Sanofi S.A. is a French multinational pharmaceutical company that engages in research and development, manufacturing and marketing of pharmaceutical products. The company covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines. |
 |
www.deichmann.com |
If you would like to sponsor the NET-Liver-Metastases Consensus Conference, please contact the conference organisers by using the form below: